Likewise, research into MCH-based therapeutics has historically been focused on the hypothesis that interfering with this function in humans will lead to reduced food consumption and weight-loss, potentially constituting an effective treatment for obesity. The gene discussed is PMCH; the disease is obesity due to melanocortin 4 receptor deficiency.